<DOC>
	<DOCNO>NCT02956239</DOCNO>
	<brief_summary>This project develop , test produce lightweight , cordless , battery driven rechargeable hand-held device treat cervical precancer ( Liger Thermal Coagulator ) . The study evaluate effectiveness compare current standard treatment ( cryocautery ) use part screen treat programme use Visual Inspection Acetic acid ( VIA ) Sub Saharan Africa .</brief_summary>
	<brief_title>Development , Field Testing Evaluation Efficacy Hand-held , Portable Affordable Thermo-coagulator Prevent Cervical Cancer Low- Middle-income Countries</brief_title>
	<detailed_description>This project aim improve screen treat programme cervical cancer discover best method treatment . The specific aim 1 . To develop , test produce 20 novel lightweight hand-held cordless , portable battery driven rechargeable Thermal Coagulators ( Liger Medical , Utah ) . 2 . To evaluate success / failure rate Thermal Coagulation randomise control trial compare thermal coagulation exist current standard cryocautery Large Loop Excision Transformation Zone ( LLETZ aka LEEP ) part screen treat programme Zambia . 3 . To evaluate user satisfaction score Liger Thermal Coagulator cryocautery part screen treat programme Zambia . 4 . To determine rate treatment VIA positive woman reveal histopathological examination randomly assign excised treatment case . 5 . To determine value Z scan predict normality abnormality VIA positive woman randomly assign excisional therapy In collaboration medical device company Utah , engineering performance Liger Thermal Coagulator develop test vitro vivo . 200+ Liger unit produce randomise control trial device undertaken , compare cryocautery LLETZ use efficacy user friendliness endpoint . The inclusion study arm excisional therapy allow quantify rate overtreatment VIA programme use Z scan may allow non invasive method accurately predict normality abnormality VIA positive woman .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<criteria>Positive VIA test cervical cancer screen Eligible ablative treatment Pregnancy Not voluntaily willing participate</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>cervical precancer</keyword>
	<keyword>screen</keyword>
	<keyword>treatment</keyword>
	<keyword>thermo-coagulation</keyword>
	<keyword>thermal ablation</keyword>
	<keyword>Reducing overtreatment</keyword>
</DOC>